Galaxy Biomedical Investment Co., Ltd. approved election of Liu Keyang, Xu Haijun, Pan Guigang and Liu Xingliang as non-independent directors; Wang Shengli and Xu Binghui as independent directors; and Wang Lidong and Ma Li as non-employee supervisors at the Extraordinary General Meeting held on November 3, 2022.